Form 4 for ORKA Oruka Therapeutics, Inc.
Accepted 2026-06-22 19:59:37 ET · period of report 2026-06-22 · accession 0000907654-26-000066 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-06-22 19:59 | 2026-06-22 | ORKA | Agarwal Arjun | SVP, Fin | S - Sale | $80.95 | -1,587 | 15.3K | -9% | -$128.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-22 | S | D | 888 | $80.01 | 16,011 | D | — | — | (F1) These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026. |
| 2 | Common | Common Stock | 2026-06-22 | S | D | 699 | $82.14 | 15,312 | D | — | — | (F1) These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026. |